Evolent Health Inc Cl A Com (EVH) Stock Price, Quote & News

Company Profile

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggreg...

Industry: Health Information Services

Sector: Healthcare

Phone: 571 389 6000

Website: www.evolent.com

Address:

1812 N. Moore Street, Suite 1705, Arlington, United States

TOMKiLA May. 13 at 12:40 PM

$EVH this year $2.4/6b revenues and $130/150m ebitda with 20m investment in AI to cut costs. Next year with potential new $900M contracts, evolent should show $3.5b revenues and a range of $270 and 300m ebitda. Ps: evolent this year is closing some contracts + ends others + the new big deal is really in the beginning of the value so, next year the ebitda will increase quickly $270M ebitda is really low %, the value should double without problem!

1 · Reply

StockHunter75 May. 13 at 12:25 AM

$EVH

0 · Reply

anachartanalyst May. 12 at 8:02 PM

$EVH https://anachart.com/wp-content/uploads/2026/05/1778616129_soc-img.jpg

0 · Reply

BPler May. 12 at 7:09 PM

$EVH Patience and adding is the game to play here, it is not a race.

0 · Reply

PatBtmn May. 12 at 6:47 PM

$EVH round 2

0 · Reply

nUme22 May. 12 at 6:42 PM

$EVH called it... Loaded big at around 2...

0 · Reply

riedela May. 12 at 5:42 PM

$EVH WTF

0 · Reply

farkws May. 12 at 5:23 PM

$EVH will go down hard, time to short

0 · Reply

Stonkey May. 12 at 2:04 PM

$EVH Eternal loser just keeps on losing each and every day......

0 · Reply

BRITLS May. 11 at 3:44 PM

$EVH news or just losing momentum?

3 · Reply

Evolent Health price target raised to $6 from $5 at Canaccord

2026-05-07T15:15:00.000Z - 6 days ago

Evolent Health reports Q1 adjusted EPS (2c), consensus (5c)

May 7, 2026, 8:00 AM EDT - 6 days ago

Evolent Health Earnings Call Transcript: Q1 2026

May 7, 2026, 7:00 AM EDT - 6 days ago

Evolent Announces First Quarter 2026 Results

Apr 7, 2026, 4:30 PM EDT - 5 weeks ago

Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026

2026-03-19T12:56:59.000Z - 7 weeks ago

Evolent Health appoints Archie Mayani as Chief Product Officer

Mar 19, 2026, 8:45 AM EDT - 7 weeks ago

Evolent announces appointment of Archie Mayani as chief product officer

Mar 17, 2026, 10:00 AM EDT - 2 months ago

Evolent Health Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

2026-03-02T12:42:26.000Z - 2 months ago

Evolent Health price target lowered to $6 from $12 at Oppenheimer

Feb 26, 2026, 5:00 PM EST - 2 months ago

Evolent to Participate in Upcoming Investor Conferences

2026-02-26T13:16:53.000Z - 2 months ago

Evolent Health price target lowered to $5 from $10 at UBS

2026-02-26T11:37:03.000Z - 2 months ago

Evolent Health price target lowered to $4 from $6 at Citi

2026-02-25T18:25:33.000Z - 2 months ago

Evolent Health price target lowered to $6 from $10 at Truist

2026-02-25T12:24:40.000Z - 2 months ago

Evolent Health price target lowered to $8 from $10 at BTIG

2026-02-25T11:57:07.000Z - 2 months ago

Evolent Health price target lowered to $4 from $9 at Canaccord

2026-02-25T09:40:30.000Z - 2 months ago

Evolent Health downgraded to Sector Weight from Overweight at KeyBanc

Feb 24, 2026, 5:00 PM EST - 2 months ago

Evolent Health Earnings Call Transcript: Q4 2025

2026-02-24T21:20:38.000Z - 2 months ago

Evolent Health reports Q4 adjusted EPS 8c vs. (2c) last year

2026-02-24T21:18:28.000Z - 2 months ago

Evolent Health sees FY26 revenue $2.4B-$2.6B, consensus $2.38B

Feb 24, 2026, 4:10 PM EST - 2 months ago

Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results

Feb 4, 2026, 11:02 AM EST - 3 months ago

Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026

2026-02-02T12:15:14.000Z - 3 months ago

Evolent Health price target lowered to $10 from $16 at BTIG

2026-01-09T12:15:58.000Z - 4 months ago

Evolent Health price target lowered to $6 from $9.50 at Citi

2026-01-06T10:40:32.000Z - 4 months ago

Evolent Health price target lowered to $10 from $11 at Citizens

Jan 2, 2026, 4:15 PM EST - 4 months ago

Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08

Dec 2, 2025, 11:00 AM EST - 5 months ago

Evolent Health Transcript: Piper Sandler 37th Annual Healthcare Conference

2025-11-21T11:35:09.000Z - 6 months ago

Evolent Health price target lowered to $9.50 from $11.50 at Citi

2025-11-17T12:30:39.000Z - 6 months ago

Evolent Health price target lowered to $7 from $13 at JPMorgan

2025-11-14T11:26:02.000Z - 6 months ago

Evolent Health price target lowered to $9 from $16 at Canaccord

2025-11-13T14:40:40.000Z - 6 months ago

Evolent Health upgraded to Overweight at Stephens with sentiment near bottom

Nov 6, 2025, 5:00 PM EST - 6 months ago

Evolent Health Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:12 PM EST - 6 months ago

Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden

Nov 6, 2025, 4:10 PM EST - 6 months ago

Evolent Announces Third Quarter 2025 Results

Oct 9, 2025, 8:30 AM EDT - 7 months ago

Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Sep 23, 2025, 4:10 PM EDT - 8 months ago

Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners

PRVA

Aug 19, 2025, 7:00 AM EDT - 9 months ago

Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock

Aug 18, 2025, 4:05 PM EDT - 9 months ago

Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock

Aug 13, 2025, 9:30 AM EDT - 9 months ago

Evolent Health Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 7, 2025, 5:00 PM EDT - 9 months ago

Evolent Health Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:10 PM EDT - 9 months ago

Evolent Announces Second Quarter 2025 Results

Jul 14, 2025, 8:00 AM EDT - 10 months ago

Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025

Jul 9, 2025, 8:00 AM EDT - 11 months ago

Evolent announces key appointments to leadership team

Jun 20, 2025, 6:30 AM EDT - 11 months ago

Evolent reiterates Q2 and full year guidance for Adjusted EBITDA

Jun 3, 2025, 2:20 PM EDT - 1 year ago

Evolent Health Transcript: 45th Annual William Blair Growth Stock Conference

May 8, 2025, 5:00 PM EDT - 1 year ago

Evolent Health Earnings Call Transcript: Q1 2025

May 8, 2025, 4:10 PM EDT - 1 year ago

Evolent Announces First Quarter 2025 Results

Apr 22, 2025, 6:30 AM EDT - 1 year ago

Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors

Apr 15, 2025, 9:00 AM EDT - 1 year ago

Evolent program achieves 20% reduction in use of low-value oncology regimens

Apr 10, 2025, 5:00 PM EDT - 1 year ago

Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025

Mar 4, 2025, 1:50 PM EST - 1 year ago

Evolent Health Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 20, 2025, 5:00 PM EST - 1 year ago

Evolent Health Earnings Call Transcript: Q4 2024

Feb 20, 2025, 4:10 PM EST - 1 year ago

Evolent Announces Fourth Quarter and Full Year 2024 Results

Feb 4, 2025, 7:00 AM EST - 1 year ago

Evolent Health Announces Changes to Board of Directors

Jan 27, 2025, 5:00 PM EST - 1 year ago

Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025

Dec 18, 2024, 4:10 PM EST - 1 year ago

Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1

Dec 3, 2024, 3:15 PM EST - 1 year ago

Evolent Health Transcript: Citi's 2024 Global Healthcare Conference

Nov 20, 2024, 11:00 AM EST - 1 year ago

Evolent Health Transcript: Stephens 26th Annual Investment Conference | NASH2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Evolent Health Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:10 PM EST - 1 year ago

Evolent Announces Third Quarter 2024 Results

Oct 11, 2024, 8:00 AM EDT - 1 year ago

Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024

Oct 2, 2024, 12:08 PM EDT - 1 year ago

Evolent Health Inc (EVH) Stock Price Down 3.2% on Oct 2

Aug 22, 2024, 1:22 PM EDT - 1 year ago

Exclusive: Evolent Health in sale talks after inbound interest, sources say

Aug 13, 2024, 8:30 AM EDT - 1 year ago

Evolent Health Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 8, 2024, 5:00 PM EDT - 1 year ago

Evolent Health Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:10 PM EDT - 1 year ago

Evolent Announces Second Quarter 2024 Results

Jul 11, 2024, 8:00 AM EDT - 1 year ago

Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Jun 4, 2024, 10:00 AM EDT - 2 years ago

Evolent Health Transcript: William Blair 44th Annual Growth Stock Conference

Jun 4, 2024, 7:00 AM EDT - 2 years ago

Evolent signs agreement to acquire artificial intelligence utilization management products and team from Machinify

May 29, 2024, 2:40 PM EDT - 2 years ago

Evolent Health Transcript: 2024 Leerink Partners Healthcare Crossroads Conference

May 15, 2024, 3:05 PM EDT - 2 years ago

Evolent Health Transcript: RBC Capital Markets 2024 Global Healthcare Conference

May 9, 2024, 5:00 PM EDT - 2 years ago

Evolent Health Earnings Call Transcript: Q1 2024

May 9, 2024, 4:15 PM EDT - 2 years ago

Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.

May 9, 2024, 4:10 PM EDT - 2 years ago

Evolent Announces First Quarter 2024 Results

Apr 18, 2024, 4:30 PM EDT - 2 years ago

Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024

Mar 12, 2024, 2:35 PM EDT - 2 years ago

Evolent Health Transcript: Barclays 26th Annual Global Healthcare Conference 2024

Mar 4, 2024, 1:30 PM EST - 2 years ago

Evolent Health Transcript: TD Cowen 44th Annual Health Care Conference

Feb 22, 2024, 5:00 PM EST - 2 years ago

Evolent Health Earnings Call Transcript: Q4 2023

Feb 22, 2024, 4:10 PM EST - 2 years ago

Evolent Announces Fourth Quarter and Full Year 2023 Results

Feb 14, 2024, 4:10 PM EST - 2 years ago

Evolent Adds Russell Glass, Headspace CEO, to Board of Directors

Jan 25, 2024, 7:00 AM EST - 2 years ago

Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024

Jan 9, 2024, 6:45 PM EST - 2 years ago

Evolent Health Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Dec 5, 2023, 10:59 PM EST - 2 years ago

Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan

Dec 5, 2023, 7:00 AM EST - 2 years ago

Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan

Nov 2, 2023, 5:00 PM EDT - 2 years ago

Evolent Health Earnings Call Transcript: Q3 2023

Nov 2, 2023, 4:10 PM EDT - 2 years ago

Evolent Announces Third Quarter 2023 Results

Oct 10, 2023, 5:30 PM EDT - 2 years ago

Evolent to release third quarter financial results on Thursday, Nov. 2, 2023, and participate in upcoming investor conferences

Aug 24, 2023, 5:21 PM EDT - 2 years ago

Evolent saves Medicare more than $55 million through its Medicare Shared Savings Program ACO

Aug 8, 2023, 5:00 PM EDT - 3 years ago

Evolent Health to Participate in Upcoming Conferences

Aug 2, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Earnings Call Transcript: Q2 2023

Aug 2, 2023, 4:10 PM EDT - 3 years ago

Evolent Announces Second Quarter 2023 Results

Jul 26, 2023, 4:42 PM EDT - 3 years ago

Evolent welcomes Toyin Ajayi to its Board of Directors

Jul 13, 2023, 4:15 PM EDT - 3 years ago

Evolent to Release Second Quarter Financial Results on Wednesday, August 2, 2023

Jul 11, 2023, 9:00 AM EDT - 3 years ago

Evolent Health announces focus on value-based specialty care with rebrand, unification of all solutions under "Evolent"

May 23, 2023, 10:00 AM EDT - 3 years ago

Evolent Health Transcript: Investor Day 2023

May 3, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Earnings Call Transcript: Q1 2023

May 3, 2023, 4:10 PM EDT - 3 years ago

Evolent Health Announces First Quarter 2023 Results

Apr 20, 2023, 7:19 PM EDT - 3 years ago

Fast Pitch: Essex Investments's co-CEO sees growth in this health care name

TOMKiLA May. 13 at 12:40 PM

1 · Reply

StockHunter75 May. 13 at 12:25 AM

$EVH

0 · Reply

anachartanalyst May. 12 at 8:02 PM

$EVH https://anachart.com/wp-content/uploads/2026/05/1778616129_soc-img.jpg

0 · Reply

BPler May. 12 at 7:09 PM

$EVH Patience and adding is the game to play here, it is not a race.

0 · Reply

PatBtmn May. 12 at 6:47 PM

$EVH round 2

0 · Reply

nUme22 May. 12 at 6:42 PM

$EVH called it... Loaded big at around 2...

0 · Reply

riedela May. 12 at 5:42 PM

$EVH WTF

0 · Reply

farkws May. 12 at 5:23 PM

$EVH will go down hard, time to short

0 · Reply

Stonkey May. 12 at 2:04 PM

$EVH Eternal loser just keeps on losing each and every day......

0 · Reply

BRITLS May. 11 at 3:44 PM

$EVH news or just losing momentum?

3 · Reply

Stonkey May. 11 at 3:01 PM

$EVH Eternal loser can't stop losing.....

0 · Reply

MarketBeat May. 10 at 9:13 AM

https://marketbeat.com/a/8645355/ $EVH Evolent Health Q1 Earnings Call Highlights

0 · Reply

XQuise May. 8 at 4:03 PM

$EVH 😉🧠👈🏻

0 · Reply

AveraveJoeTrader May. 8 at 1:58 PM

$CTNT $IREN $EVH All on watch..great chart breakdown here..👇🏻👇🏻🎉 https://x.com/autumnsdad1/status/2052723566596993089?s=61

0 · Reply

Stonkey May. 8 at 1:45 PM

$EVH Eternal loser does what it does best.....losing.

1 · Reply

Etiqute May. 8 at 1:18 PM

$EVH PriceFalling below the 50-day Moving Average ($3.75) would invalidate the current bullish trend and likely trigger a "sell" signal. Analyst ContextWall Street sentiment has recently shifted following the Q1 2026 earnings report:Needham raised its price target from $4 to $5.00 on May 7, maintaining a "Buy" rating.Consensus Target: The average 12-month target currently stands at $6.12, suggesting a potential upside of approximately 42% from current levels.

0 · Reply

Etiqute May. 8 at 12:56 PM

$EVH the key technical trigger price for Evolent Health (EVH) to signal a further bullish breakout is $4.54.THIS level represents the recent day high hit during its post-earnings surge on May 7. Breaking above this resistance is widely considered a "buy signal" for traders looking for continued momentum toward the next significant resistance level near $5.59.CRITICAL Price LevelsCurrent market data and technical reports from Investing.com and StockInvest.us highlight these immediate triggers:Upside Trigger ($4.54 – $4.67): A decisive break above this range is expected to issue a new short-term buy signal, potentially pushing the stock toward analyst median targets of $5.00 – $6.12.SUPPORT Level ($4.00): This "trend roof" was recently broken and now serves as the primary support. If the stock pulls back, this is the level where buyers are expected to step in.Downside Warning ($3.75):

0 · Reply

Etiqute May. 8 at 12:41 PM

$EVH Volume & SentimentVolume: The stock has experienced high trading volume, with recent trading days showing elevated interest compared to the 30-day average, signaling strong buying conviction.Volatility: High volatility is present over the last 5 trading days, offering both risk and opportunity.Market Sentiment: Analyst consensus remains a Buy/Strong Buy.

0 · Reply

Etiqute May. 8 at 12:35 PM

$EVH As of May 8, 2026, the technicals and volume trend for Evolent Health (EVH) over the last 5 trading days are strongly bullish, characterized by a significant price surge following Q1 2026 earnings, despite long-term volatility.5-Day Technical Analysis & TrendTrend: The stock is in an uptrend, with shares soaring by over 13% to over 15% following the May 7, 2026, earnings announcement. $EVH As of May 8, 2026, the technicals and volume trend for Evolent Health (EVH) over the last 5 trading days are strongly bullish, characterized by a significant price surge following Q1 2026 earnings, despite long-term volatility.5-Day Technical Analysis & TrendTrend: The stock is in an uptrend, with shares soaring by over 13% to over 15% following the May 7, 2026, earnings announcement.

0 · Reply

TOMKiLA May. 8 at 10:13 AM

$EVH let’s wait another $200M new contract signed in q2 2026! Evolent is telling us a lot of things such as to find better deal with huge players to work with for years and growth together

0 · Reply

BPler May. 8 at 5:37 AM

$EVH Not even 2 years ago this was a 30+ company, with a buyout offer for 36 USD. Since that day they declined the offer from a private equity firm this was shorted down to oblivion. Seeing the financial rising up and the low price, will bring more and more long-term investors.

0 · Reply

PatBtmn May. 8 at 12:16 AM

$EVH nice AH.

0 · Reply

Market Cap	442.09M
Revenue (ttm)	1.88B
Net Income (ttm)	-534.51M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-28.49%
Debt to Equity Ratio	2.46

Volume	3,433,300
Avg Vol	2,958,450
Day's Range	N/A - N/A
Shares Out	111.64M
Stochastic %K	62%
Beta	0.83
Analysts	Strong Sell
Price Target	$5.86